New Double-bridged Peptides Can Target Proteins That Cause Angioedema, Study Finds
A new strategy that uses small protein fragments with an unconventional structure may be used to target many different disease-related proteins, according to French researchers. The team at the Ecole Polytechnique Fédérale de Lausanne has already developed a molecule that targets kallikrein, the protein that causes hereditary angioedema, and another targeting…